NCBiotech News

GreenLight Biosciences, which uses RNA-based technology for agricultural and human health applications, is adding more than 60,000 square feet and hiring some 16 more people at its RTP R&D operations.

A dozen entrepreneurial companies, half of them bioscience related, have received investments totaling $1 million to help them grow in Winston-Salem.

Durham gene therapy company Kriya Therapeutics has purchased neighboring startup Warden Bio, for an undisclosed sum, to expand its rare diseases capabilities.

Wake Tech Community College recently launched a campaign, Building Tomorrow’s Talent, seeking industry partners to support the new biotech building on its RTP campus.

Marrone Bio Innovations, a publicly traded company focused on sustainable bioprotection and plant health solutions, has relocated its corporate headquarters from Davis, Calif., to Raleigh.

Supported by a grant from NCBiotech, research team at Appalachian State University is investigating effective treatments for one of the most aggressive types of breast cancer — with the goal of reducing adverse side effects.

Thermo Fisher Scientific, Inc. has completed its acquisition of Wilmington-based global contract research organization PPD. The $17.4 billion deal was finalized in December.

Developers have announced plans to build a $1 billion, 109-acre mixed-use life sciences campus in the heart of Morrisville, to be called Spark.

The Yield, a life sciences campus focusing on biomanufacturing, office and lab space with retail amenities, is about to get an official groundbreaking on 200 acres in Holly Springs.

Greensboro-based URO-1, an innovator of medical devices for urology and urogynecology, has achieved multiple milestones toward commercializing its products for prostate biopsy and other procedures.

Life sciences-related expansions, relocations or new facilities representing almost $4 billion in investment and 4,800 jobs were announced across the state in 2021.

A publicly traded clinical research and testing company, Science 37, will be moving its headquarters to Morrisville, creating some 250 new jobs in the next several years.

Morrisville-based Heat Biologics has signed a definitive merger agreement to acquire Elusys Therapeutics, a biodefense company that makes a treatment for anthrax, a deadly infectious disease potentially spread by bioterrorism or biowarfare.

A new national public/private consortium designed to boost the development of gene therapies also holds promise for North Carolina, as a major global leader in cell and gene therapies.

Morrisville-based Metabolon, a metabolomics data and insights company, will work with two major medical centers in Boston to study the biology underlying lactation for better maternal and infant health.